Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

Abstract Background An infection with high-risk human papillomavirus (HPV) is the obligatory aetiological factor for the development of cervical cancer. In Switzerland, the prevention strategy for cervical cancer is based on primary prevention via HPV vaccination and secondary prevention with an opp...

Full description

Bibliographic Details
Main Authors: André B. Kind, Andrew Pavelyev, Smita Kothari, Nadia El Mouaddin, Aurélie Schmidt, Edith Morais, Patrik Guggisberg, Florian Lienert
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Public Health
Subjects:
HPV vaccination
Cervical disease
Impact
Gender-neutral vaccination
Switzerland
HPV
Online Access:http://link.springer.com/article/10.1186/s12889-020-08840-0

Internet

http://link.springer.com/article/10.1186/s12889-020-08840-0

Similar Items